The bill amends the establishment of the Controlled Substances Advisory Committee by changing its affiliation from the Department of Law to the Department of Commerce, Community, and Economic Development. This change reflects a shift in oversight and management of the committee, which is responsible for advising on matters related to controlled substances.

Additionally, the composition of the committee remains unchanged, consisting of various appointed members including the attorney general or their designee, commissioners from family and community services and public safety, the president of the Board of Pharmacy, a peace officer, a physician, a psychiatrist, and two other individuals appointed by the governor. The bill aims to streamline the committee's operations under the new department while maintaining its current structure and membership.

Statutes affected:
SB0233A, AM SB 233, introduced 02/04/2026: 11.71.100